A Llombart

Author PubWeight™ 17.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM). Ann Oncol 2010 3.00
2 Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results. Ann Oncol 2012 2.16
3 Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy. Ann Oncol 2006 1.23
4 Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis. Ann Oncol 2011 1.09
5 Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer. Br J Cancer 2010 1.05
6 The incidence and significance of epithelioid and sarcoid-like cellular reaction in the stromata of malignant tumours. A morphological and experimental study. Eur J Cancer 1970 0.96
7 Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines. Br J Dermatol 2008 0.92
8 Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Ann Oncol 2014 0.89
9 Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trial. Semin Oncol 2000 0.87
10 Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancer. Ann Oncol 1999 0.80
11 Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response. Clin Transl Oncol 2013 0.80
12 Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. Med Pediatr Oncol 1995 0.80
13 Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry. Ann Oncol 2013 0.77
14 [Angiosarcoma of the breast. Apropos of 8 cases and review of the literature]. Bull Cancer 1997 0.75
15 Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study. Breast Cancer Res Treat 2015 0.75
16 Barrett's esophagus, markers to distinguish risk groups. Rev Esp Enferm Dig 1998 0.75
17 The autopsy in modern oncology: a quality assessment of clinical care. Ann Oncol 1991 0.75
18 [Primary hepatic cancer, as a diagnostic problem]. Rev Clin Esp 1967 0.75
19 [On sympathetic participation in Recklinghausen's disease. Study of 5 cases of peripheral sympathetic myxoneuroma]. Ann Anat Pathol (Paris) 1968 0.75
20 Ovarian sex cord tumor with annular tubules in a woman with premature ovarian failure. Fertil Steril 2001 0.75
21 [Coccygeal localization of neuro-pericytial glomangioma]. Ann Anat Pathol (Paris) 1970 0.75
22 [Visceral leishmaniasis and multiple organ failure]. Enferm Infecc Microbiol Clin 1993 0.75
23 In vitro utilization of diethylstilbestrol by rat liver. J Pharm Sci 1968 0.75
24 [Isolation and antimitotic activity of lactones extracted from Podophyllum emodi]. Rev Esp Fisiol 1970 0.75
25 [Nerve regeneration in the anterior gastric wall after gastrotomy and posterior truncal vagotomy in the rat]. Rev Esp Enferm Dig 1993 0.75
26 [Mesenchymal breast sarcomas: general review]. Arch Anat Cytol Pathol 1995 0.75
27 [43-year-old male, with severe marrow aplasia, fever, abdominal pain and hemoptysis]. Med Clin (Barc) 1990 0.75
28 Current controversies in the management of breast cancer. Clin Transl Oncol 2010 0.75
29 [Ewing type reticular sarcoma of bone marrow. Optic, histochemical and electron study of 2 cases]. Ann Anat Pathol (Paris) 1971 0.75
30 [Chronic polymyositis. (Considerations on 2 cases)]. Rev Clin Esp 1966 0.75
31 On the sympathetic nature of some forms of Recklinghausen's disease: a study of six cases. Trab Inst Cajal Invest Biol 1970 0.75
32 Some histochemical alterations induced by the methylhydrazine derivative Natulan on two experimental ascites tumors. Oncology 1970 0.75
33 Current controversies in the management of early breast cancer. Clin Transl Oncol 2007 0.75
34 Tumoral drugs as possible blastogenic agents the problem of anti-blastic medication. Osterr Z Onkol 1976 0.75
35 Treatment with a nonanthracycline regimen in advanced breast cancer: vinorelbine, cyclophosphamide, and 5-fluorouracil with folinic acid. Am J Clin Oncol 1999 0.75
36 Antimitotic activity of the methylhydrazine derivative Natulan in the ehrlich ascites carcinoma; dose-effect relationship. Oncology 1969 0.75